JP2004509839A5 - - Google Patents

Download PDF

Info

Publication number
JP2004509839A5
JP2004509839A5 JP2001580904A JP2001580904A JP2004509839A5 JP 2004509839 A5 JP2004509839 A5 JP 2004509839A5 JP 2001580904 A JP2001580904 A JP 2001580904A JP 2001580904 A JP2001580904 A JP 2001580904A JP 2004509839 A5 JP2004509839 A5 JP 2004509839A5
Authority
JP
Japan
Prior art keywords
chromen
ylmethyl
pyrimidine
diamine
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001580904A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004509839A (ja
JP4033676B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2001/004541 external-priority patent/WO2001083476A1/en
Publication of JP2004509839A publication Critical patent/JP2004509839A/ja
Publication of JP2004509839A5 publication Critical patent/JP2004509839A5/ja
Application granted granted Critical
Publication of JP4033676B2 publication Critical patent/JP4033676B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2001580904A 2000-04-27 2001-04-20 抗菌剤としてのクロメニルメチルピリミジンジアミン類 Expired - Fee Related JP4033676B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00108945 2000-04-27
PCT/EP2001/004541 WO2001083476A1 (en) 2000-04-27 2001-04-20 Chromenylmethyl pyrimidinediamines as antibacterial agents

Publications (3)

Publication Number Publication Date
JP2004509839A JP2004509839A (ja) 2004-04-02
JP2004509839A5 true JP2004509839A5 (cg-RX-API-DMAC7.html) 2005-01-27
JP4033676B2 JP4033676B2 (ja) 2008-01-16

Family

ID=8168565

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001580904A Expired - Fee Related JP4033676B2 (ja) 2000-04-27 2001-04-20 抗菌剤としてのクロメニルメチルピリミジンジアミン類

Country Status (14)

Country Link
US (1) US6818649B2 (cg-RX-API-DMAC7.html)
EP (1) EP1278742B1 (cg-RX-API-DMAC7.html)
JP (1) JP4033676B2 (cg-RX-API-DMAC7.html)
KR (1) KR20020093966A (cg-RX-API-DMAC7.html)
CN (1) CN1249057C (cg-RX-API-DMAC7.html)
AT (1) ATE284882T1 (cg-RX-API-DMAC7.html)
AU (1) AU2001252269A1 (cg-RX-API-DMAC7.html)
BR (1) BR0110255A (cg-RX-API-DMAC7.html)
CA (1) CA2405614A1 (cg-RX-API-DMAC7.html)
DE (1) DE60107832T2 (cg-RX-API-DMAC7.html)
ES (1) ES2232614T3 (cg-RX-API-DMAC7.html)
MX (1) MXPA02010518A (cg-RX-API-DMAC7.html)
WO (1) WO2001083476A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200208271B (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI243173B (en) 1999-11-17 2005-11-11 Akzo Nobel Nv Spiro[2H-1-benzopyran-2,4'-piperidine] derivatives
KR20140015122A (ko) 2003-10-01 2014-02-06 아돌로 코포레이션 스피로시클릭 헤테로시클릭 유도체 및 이의 사용 방법
US7449458B2 (en) * 2005-01-19 2008-11-11 Rigel Pharmaceuticals, Inc. Prodrugs of 2,4-pyrimidinediamine compounds and their uses
US7598261B2 (en) * 2005-03-31 2009-10-06 Adolor Corporation Spirocyclic heterocyclic derivatives and methods of their use
EP1770089A1 (en) * 2005-10-03 2007-04-04 Institut Pasteur Pyranodibenzofuran derivatives with antifungal and antibacterial activity
US7855194B2 (en) 2006-03-27 2010-12-21 Hoffmann-La Roche Inc. Pyrimidine, quinazoline, pteridine and triazine derivatives
US7576207B2 (en) 2006-04-06 2009-08-18 Adolor Corporation Spirocyclic heterocyclic derivatives and methods of their use
CN109134493A (zh) * 2018-09-19 2019-01-04 浙江师范大学 一种具有抗菌活性的2-氧代色烯并噻吩衍生物及其合成方法和应用
CN109988156B (zh) * 2019-03-12 2021-12-28 广东中科药物研究有限公司 一种氨基嘧啶化合物
CN112824412B (zh) * 2019-11-21 2022-09-16 中国科学院大连化学物理研究所 手性1′H-螺[吲哚啉-3,4′-吡喃并[2,3-c]吡唑]-2-酮类化合物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2238521C (en) * 1995-12-04 2005-08-16 F. Hoffmann-La Roche Ag Diaminopyrimidines, pharmaceutical compositions containing them and their use as antibacterial

Similar Documents

Publication Publication Date Title
JP2001526218A5 (cg-RX-API-DMAC7.html)
RU96115142A (ru) Производные 5-(2-имидазолиниламино)бензимидазола, их получение и применение в качестве агонистов альфа-2-адреноцепторов
RU2002107975A (ru) Глюкопиранозилоксипиразольные производные, лекарственные композиции, содержащие эти производные, и промежуточные соединения для их получения
JP2005511547A5 (cg-RX-API-DMAC7.html)
JP2010504346A5 (cg-RX-API-DMAC7.html)
JP2005530811A5 (cg-RX-API-DMAC7.html)
CA2361057A1 (en) Quinoline derivatives and quinazoline derivatives
JP2010510233A5 (cg-RX-API-DMAC7.html)
CA2445333A1 (en) Quinoline derivatives and quinazoline derivatives having azolyl group
JP2004531544A5 (cg-RX-API-DMAC7.html)
KR960704884A (ko) 항종양제 또는 항바이러스제로서의 디스타마이신 A 동족체 (Distamycin A analogues as antitumour or antiviral agents)
JP2011500658A5 (cg-RX-API-DMAC7.html)
JP2013512277A5 (cg-RX-API-DMAC7.html)
JP2010527983A5 (cg-RX-API-DMAC7.html)
JP2005527542A5 (cg-RX-API-DMAC7.html)
KR890008137A (ko) 3-[4(1-치환된-4-피페라지닐)부틸]-4-티아졸리디노 이의 제조방법 및 약제로서의 이의 용도
EP2196454A3 (en) Exo-and diastereo-selective syntheses of himbacine analogs
JP2003534359A5 (cg-RX-API-DMAC7.html)
JP2012512863A5 (cg-RX-API-DMAC7.html)
CA2336412A1 (en) Medicament for treatment of diabetes
JP2003503449A5 (cg-RX-API-DMAC7.html)
JP2013501726A5 (cg-RX-API-DMAC7.html)
JP2003012668A5 (cg-RX-API-DMAC7.html)
CA2267315A1 (en) Ethylamine derivatives
JP2004523478A5 (cg-RX-API-DMAC7.html)